October 2021 tender notification
Pharmac is pleased to provide the latest tender results.
Download the tender notification [PDF 47 KB]
Tender results
PHARMAC has resolved to award tenders for Principal Supply Status for some products included in the 2020/21 Invitation to Tender, dated 2 November 2020.
Some of the pharmaceuticals that will be delisted when the period of Principal Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to PHARMAC, the Pharmacy Guild and the NZULM by:
- For new listings, by 4pm on 12 November 2021 or the 5th of the month prior to listing, whichever is earlier
- For price changes, by 4pm on the 12th of the month prior to the date of subsidy change
PHARMAC cannot list a product (and pharmacies cannot claim) without this information.
More information about this process and NOPC forms can be found on our website.
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link).
Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest).
PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
2020/21 Tender – Principal Supply Status applies until 30 June 2024
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
1. Tenders awarded to currently listed pharmaceuticals where at least one other brand is listed
The decisions were as follows:
|
Chemical name |
Presentation; |
Current |
New |
Principal Supply brand (Supplier) |
Date of subsidy change |
Principal Supply Status date |
Brand |
|---|---|---|---|---|---|---|---|
|
Oil in water emulsion |
Crm, 500 g tub |
$2.19 |
$2.04 |
Fatty Cream AFT (AFT Pharmaceuticals Ltd) |
1 April 2022 |
1 September 2022 |
O/W Fatty Emulsion Cream (Boucher & Muir) |
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
2. Tenders awarded to currently listed pharmaceuticals where at least one other brand is listed
The decisions were as follows:
|
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand (Supplier) |
DV Limit |
Listing date |
Principal Supply Status date |
Brand |
|---|---|---|---|---|---|---|---|---|
|
Oil in water emulsion |
Crm, 500 g tub |
$2.19 |
$2.04 |
Fatty Cream AFT (AFT Pharmaceuticals Ltd) |
5% |
1 April 2022 |
1 September 2022 |
O/W Fatty Emulsion Cream (Boucher & Muir) |
3. Tenders awarded to currently listed pharmaceuticals where no other brand is listed
The decisions were as follows:
|
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand (Supplier) |
DV Limit |
Listing date |
Principal Supply Status date |
|---|---|---|---|---|---|---|---|
|
Oil in water emulsion |
Crm, 100g tube |
$1.44 |
$1.59 |
healthE Fatty Cream (Jaychem Industries Ltd) |
5% |
1 March 2022 |
1 August 2022 |
Tender declines - Products where no tender is to be awarded for Principal Supply Status, Sole Subsidised Supply Status or Hospital Supply Status
Pharmac has resolved not to award tenders for Principal Supply Status, Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in:
2019/20 Invitation to Tender
|
Chemical name |
Line item |
|---|---|
|
Acetazolamide |
Tab 250 mg |
|
Amoxicillin clavulanate |
Grans for oral liq amoxicillin 125 mg with potassium clavulanate 31.25 mg per 5 ml |
|
Amoxicillin clavulanate |
Grans for oral liq amoxicillin 250 mg with potassium clavulanate 62.5 mg per 5 ml |
|
Bupivacaine hydrochloride |
Inj 2.5 mg per ml, 20 ml ampoule |
|
Carbimazole |
Tab 5 mg |
|
Carmellose sodium |
Eye drops 1% |
|
Ethinyloestradiol with levonorgestrel |
Tab 30 mcg with levonorgestrel 150 mcg |
|
Ethinyloestradiol with levonorgestrel |
Tab 20 mcg with levonorgestrel 100 mcg |
|
Glyceryl trinitrate |
Inj 5 mg per ml, 10 ml ampoule |
|
Ivabradine (current access) |
Tab 5 mg |
|
Ivabradine (current access) |
Tab 7.5 mg |
|
Ivabradine (widened access) |
Tab 5 mg |
|
Ivabradine (widened access) |
Tab 7.5 mg |
|
Levosimendan |
Inj 2.5 mg per ml, 5 ml |
|
Metaraminol tartrate |
Inj 0.5 mg per ml, 10 ml |
|
Metaraminol tartrate |
Inj 0.5 mg per ml, 5 ml prefilled syringe |
|
Metaraminol tartrate |
Inj 0.5 mg per ml, 10 ml prefilled syringe |
|
Morphine |
Inj 10 mg per ml, 1 ml |
|
Morphine |
Inj 15 mg per ml, 1 ml |
|
Morphine |
Inj 30 mg per ml, 1 ml ampoule |
|
Morphine |
Inj 20 mg per ml |
|
Morphine |
Inj 50 mg per 5 ml |
|
Morphine |
Inj 100 mg per 5 ml |
|
Ondansetron hydrochloride |
Inj 2 mg per ml, 4 ml |
|
Ondansetron hydrochloride |
Inj 2 mg per ml, 2 ml |
|
Piperacillin with tazobactam |
Inj 4 g with tazobactam 500 mg |
2020/21 Invitation to Tender
|
Chemical name |
Line item |
|---|---|
|
Clonidine |
Tab 25 mcg |
|
Colchicine |
Tab 500 mcg |
|
Dapsone |
Tab 25 mg |
|
Daptomycin |
Inj 350 mg - 500 mg |
|
Docusate sodium with sennosides |
Tab 50 mg with sennosides 8 mg |
|
Enoxaparin sodium |
Inj 20 mg per 0.2 ml |
|
Enoxaparin sodium |
Inj 120 mg per 0.8 ml |
|
Enoxaparin sodium |
Inj 40 mg per 0.4 ml |
|
Enoxaparin sodium |
Inj 60 mg per 0.6 ml |
|
Enoxaparin sodium |
Inj 80 mg per 0.8 ml |
|
Enoxaparin sodium |
Inj 100 mg per ml, 1 ml |
|
Enoxaparin sodium |
Inj 150 mg per ml, 1 ml |
|
Liquid paraffin with white soft paraffin |
liquid paraffin 50% with white soft paraffin 50% ointment (pack size greater than 100 g) |
|
Liquid paraffin with white soft paraffin |
liquid paraffin 50% with white soft paraffin 50% ointment (pack size 100 g or less) |
|
Lisinopril |
Tab 5 mg |
|
Lisinopril |
Tab 10 mg |
|
Lisinopril |
Tab 20 mg |
If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.For products included in the 2019/20 and 2020/21 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to Pharmac Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.